Beyond Gummies: How OLLY is Revolutionizing Supplements with Mochi
For many, the daily vitamin habit is a chore that eventually falls by the wayside. Hanneke Willenborg, CEO of OLLY, argues that the failure lies in a lack of enjoyment. By transforming the supplement experience into a delightful ritual, OLLY ascended to the top of the gummy vitamin market. Now, under the umbrella of Unilever, the brand is pushing boundaries again with the launch of Mochi Bites—a three-year development project available in Sleep, Energy, Beauty, and Women’s Multi formulations. Despite its 2019 acquisition, OLLY has maintained consistent double-digit growth, proving that the combination of rigorous science and consumer-centric design is a winning formula.
Redefining the Vitamin Category
When OLLY launched in 2015, the supplement aisle was stagnant and overly focused on raw ingredients. Willenborg notes that the brand’s success stems from a four-pillar strategy: prioritizing benefits over ingredients, aesthetic packaging that consumers want to display, a foundation in clinical science, and an emphasis on pure enjoyment. By solving the "boredom" factor, OLLY has achieved significantly higher repeat purchase rates than its competitors.
The Evolution of Innovation
Since joining the Unilever family, OLLY has leveraged its parent company’s resources to scale rapidly. Willenborg highlights that the brand’s growth is fueled by a relentless cycle of innovation, aggressive retail distribution, and increased marketing reach. As a certified B Corp, OLLY aligns with mission-driven peers like Ben & Jerry’s, yet distinguishes itself through a unique "zig-zag" approach to product development—entering spaces where competitors have become complacent.
Developing the Mochi Experience
The introduction of Mochi Bites represents a strategic expansion rather than a replacement for the company’s flagship gummies. Chief Revenue Officer Bryan Ferschinger explains that with over 60% of consumers seeking more engaging supplement formats, Mochi Bites serves as a premium, science-backed alternative. The development process was intensive, requiring a global search for inspiration in Asian wellness trends and three years of technical refinement to ensure the product remains stable and effective for 18 months.
Data-Driven Trust and Future Growth
In an industry often clouded by marketing hype, OLLY is doubling down on transparency. The company is investing heavily in its own double-blind clinical trials to validate product efficacy, such as the recent findings on its Mellow Menopause line. By focusing on high-quality, NSF-certified products, OLLY aims to set a new industry standard. As the brand looks toward the future, the focus remains on making wellness accessible and habit-forming, ensuring that as consumers take more control over their health, OLLY remains their primary partner in that journey.